• L04AF01 4 medications
• L04AF02 2 medications
• L04AF03 3 medications
• L04AF04 2 medications
• L04AF07 1 medications
• L04AF08 1 medications

medicationsWithCode L04AF

• JYSELECA 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  FILGOTINIB MALEATE	127,24 mg

  ATC code: L04A, L04AF, L04AF04

  Manufacturer: Alfasigma S.P.A.

• JYSELECA 200 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  FILGOTINIB MALEATE	254,48 mg

  ATC code: L04A, L04AF, L04AF04

  Manufacturer: Alfasigma S.P.A.

• Litfulo 50 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  Ritlecitinib Tosylate	80,12 mg

  ATC code: L04A, L04AF, L04AF08

  Manufacturer: Pfizer Europe Ma Eeig

• Olumiant 2 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  BARICITINIB	2,00 mg

  ATC code: L04A, L04AF, L04AF02

  Manufacturer: Eli Lilly Nederland B.V.

• Olumiant 4 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  BARICITINIB	4,00 mg

  ATC code: L04A, L04AF, L04AF02

  Manufacturer: Eli Lilly Nederland B.V.

• Rinvoq 15 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  UPADACITINIB HEMIHYDRATE	15,4 mg

  ATC code: L04A, L04AF, L04AF03

  Manufacturer: Abbvie Deutschland Gmbh & Co. Kg

• Rinvoq 30 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  UPADACITINIB HEMIHYDRATE	30,7 mg

  ATC code: L04A, L04AF, L04AF03

  Manufacturer: Abbvie Deutschland Gmbh & Co. Kg

• Rinvoq 45 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  UPADACITINIB HEMIHYDRATE	46,1 mg

  ATC code: L04A, L04AF, L04AF03

  Manufacturer: Abbvie Deutschland Gmbh & Co. Kg

• Sotyktu 6 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  DEUCRAVACITINIB	6 mg

  ATC code: L04A, L04AF, L04AF07

  Manufacturer: Bristol-Myers Squibb Pharma Eeig

• Xeljanz 1 mg/ml oral solution

  Form: solution, oral

  Active substance	Dosage
  TOFACITINIB CITRATE	1,62 mg

  ATC code: L04A, L04AF, L04AF01

  Manufacturer: Pfizer Europe Ma Eeig

• Xeljanz 10 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TOFACITINIB CITRATE	16,155 mg

  ATC code: L04A, L04AF, L04AF01

  Manufacturer: Pfizer Europe Ma Eeig

• Xeljanz 11 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TOFACITINIB CITRATE	17,77 mg

  ATC code: L04A, L04AF, L04AF01

  Manufacturer: Pfizer Europe Ma Eeig

• Xeljanz 5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TOFACITINIB CITRATE	8,078 mg

  ATC code: L04A, L04AF, L04AF01

  Manufacturer: Pfizer Europe Ma Eeig